Scarlet fever caused by Group A strep has recently broken out in the UK. According to the latest data from the UK Health Security Agency (UKHSA), the number of infections of Group A strep has exceeded annual expectations. In the next few months, It is very likely that we will see the number of cases continue to rise! In Taiwan, Group A strep infection is more likely to occur between March and May, and the main targets are children who aged 3 to 10. After causing scarlet fever, there may be complications such as otitis media, throat abscess, pneumonia, meningitis, bone or joint problems, etc. and a chance of causing the rarer toxic shock syndrome.

In order to prevent the spread of Streptococcus A and allow us to detect pathogens early, ZeptoMetrix, a manufacturer of molecular standards recommended by the FDA, provides you with accurate and reliable test results on Streptococcus A!

NATtrol™ - CRITICAL INFECTIOUS DISEASE PANELS & CONTROLS

ZeptoMetrix offers a range of pathogen standards for critical infectious diseases. Including group A strep, Epstein-Barr virus, BK virus, type B/C hepatitis virus, monkeypox virus, etc. And an integrated panel is available for you to choose from!

NATtrol™ products features:

1. Complete microbial particles to simulate real clinical samples (including complete genomes)

2. Inactivated to make it non-infectious (heat inactivation, UV inactivation, chemical inactivation)

3. Simple storage condition 2-8°C, stable period of 1-2 years

4. Applicable to various molecular testing platforms and analysis, monitoring the whole process from extraction to amplification steps

5. Traceable WHO international standards

6. Pathogens range from respiratory, gastrointestinal, women's health to critical infectious diseases!